Eric Hsi Selected Research

Eric Hsi Research Topics

Disease

6	Neoplasms (Cancer) 11/2019 - 12/2009
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019 - 12/2007
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 04/2010
4	Lymphoma (Lymphomas) 11/2021 - 06/2010
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 02/2012
2	Multiple Myeloma 07/2006 - 11/2002
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2004 - 11/2002
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Hypotension (Low Blood Pressure) 04/2017
1	Infections 04/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2017
1	Exanthema (Rash) 04/2017
1	Fever (Fevers) 04/2017
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 04/2017
1	Fibrosis (Cirrhosis) 03/2011
1	Pulmonary Arterial Hypertension 03/2011
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2011
1	B-Cell Prolymphocytic Leukemia 05/2005
1	Splenomegaly 05/2005
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 05/2005
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 08/2004
1	Cytopenia 02/2004
1	Large Granular Lymphocytic Leukemia 02/2004

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 04/2017 - 12/2007
3	Rituximab (Mabthera)FDA Link 01/2019 - 11/2013
2	Phosphotransferases (Kinase)IBA 11/2021 - 12/2009
2	Lenalidomide (CC 5013)FDA Link 04/2017 - 03/2015
2	Transcription Factors (Transcription Factor)IBA 02/2012 - 04/2010
2	Vincristine (Oncovin)FDA LinkGeneric 07/2006 - 11/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2006 - 11/2002
2	liposomal doxorubicin (Doxil)FDA Link 07/2006 - 11/2002
1	Immunoconjugates (Immunoconjugate)IBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2019
1	ofatumumab FDA Link 01/2019
1	idelalisibIBA 04/2017
1	Alanine Transaminase (SGPT)IBA 04/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2017
1	Cytotoxins (Cytolysins)IBA 04/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2017
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	MethyltransferasesIBA 03/2015
1	Decitabine FDA Link 03/2015
1	Azacitidine (5 Azacytidine)FDA Link 03/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	Pharmaceutical PreparationsIBA 03/2015
1	epratuzumabIBA 11/2013
1	STAT5 Transcription FactorIBA 10/2012
1	Reticulin (Reticular Fiber)IBA 03/2011
1	Hypoxia-Inducible Factor 1IBA 03/2011
1	10-propargyl-10-deazaaminopterin FDA Link 03/2011
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2010
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2010
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 12/2010
1	Imatinib Mesylate (Gleevec)FDA Link 12/2010
1	Tyrosine (L-Tyrosine)FDA Link 12/2009
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2009
1	Thalidomide (Thalomid)FDA Link 07/2006
1	fludarabineIBA 05/2005
1	Pyridinolcarbamate (P23)IBA 08/2004
1	Anaplastic Lymphoma KinaseIBA 08/2004
1	NucleophosminIBA 08/2004
1	CytokinesIBA 02/2004
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 11/2002

Therapy/Procedure

7	Therapeutics 11/2021 - 11/2002
4	Drug Therapy (Chemotherapy) 11/2013 - 11/2002
1	Immunotherapy 01/2019
1	Splenectomy 05/2005